These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36516613)

  • 1. A comparison of cancer vaccine adjuvants in clinical trials.
    Marriott M; Post B; Chablani L
    Cancer Treat Res Commun; 2023; 34():100667. PubMed ID: 36516613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma or granulocyte-macrophage colony-stimulating factor administered as adjuvants with a vaccine of irradiated autologous tumor cells from short-term cell line cultures: a randomized phase 2 trial of the cancer biotherapy research group.
    Dillman RO; Wiemann M; Nayak SK; DeLeon C; Hood K; DePriest C
    J Immunother; 2003; 26(4):367-73. PubMed ID: 12843799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of granulocyte-macrophage colony-stimulating factor and foreign helper protein as immunologic adjuvants on the T-cell response to vaccination with tyrosinase peptides.
    Scheibenbogen C; Schadendorf D; Bechrakis NE; Nagorsen D; Hofmann U; Servetopoulou F; Letsch A; Philipp A; Foerster MH; Schmittel A; Thiel E; Keilholz U
    Int J Cancer; 2003 Mar; 104(2):188-94. PubMed ID: 12569574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uses of granulocyte-macrophage colony-stimulating factor in vaccine development.
    Warren TL; Weiner GJ
    Curr Opin Hematol; 2000 May; 7(3):168-73. PubMed ID: 10786654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor as an adjuvant in tumor immunotherapy.
    Fagerberg J
    Med Oncol; 1996 Sep; 13(3):155-60. PubMed ID: 9106174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FLT3L and granulocyte macrophage colony-stimulating factor enhance the anti-tumor and immune effects of an HPV16 E6/E7 vaccine.
    Ding Z; Zhu H; Mo L; Li X; Xu R; Li T; Zhao L; Ren Y; Xu Y; Ou R
    Aging (Albany NY); 2019 Dec; 11(24):11893-11904. PubMed ID: 31881013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of granulocyte-macrophage colony-stimulating factor as vaccine adjuvant.
    Jones T; Stern A; Lin R
    Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 2():S47-53. PubMed ID: 7875153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor.
    Armitage JO
    Blood; 1998 Dec; 92(12):4491-508. PubMed ID: 9845514
    [No Abstract]   [Full Text] [Related]  

  • 9. GM-CSF as adjuvant for immunotherapy with bispecific antibodies.
    Elsässer D; Stadick H; van de Winkel JG; Valerius T
    Eur J Cancer; 1999 Aug; 35 Suppl 3():S25-8. PubMed ID: 10645218
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor.
    Liu HM; Newbrough SE; Bhatia SK; Dahle CE; Krieg AM; Weiner GJ
    Blood; 1998 Nov; 92(10):3730-6. PubMed ID: 9808567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory properties of antineoplastic drugs administered in conjunction with GM-CSF-secreting cancer cell vaccines.
    Nigam A; Yacavone RF; Zahurak ML; Johns CM; Pardoll DM; Piantadosi S; Levitsky HI; Nelson WG
    Int J Oncol; 1998 Jan; 12(1):161-70. PubMed ID: 9454900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types.
    Hong IS
    Exp Mol Med; 2016 Jul; 48(7):e242. PubMed ID: 27364892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte macrophage colony-stimulating factor has come of age: From a vaccine adjuvant to antiviral immunotherapy.
    Petrina M; Martin J; Basta S
    Cytokine Growth Factor Rev; 2021 Jun; 59():101-110. PubMed ID: 33593661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine.
    Block MS; Suman VJ; Nevala WK; Kottschade LA; Creagan ET; Kaur JS; Quevedo JF; McWilliams RR; Markovic SN
    Melanoma Res; 2011 Oct; 21(5):438-45. PubMed ID: 21697748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony-stimulating factor or interferon-gamma.
    Hrubec TC; Yan M; Ye K; Salafia CM; Holladay SD
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Dec; 288(12):1303-9. PubMed ID: 17075842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.
    Martinez Sanz P; van Rees DJ; van Zogchel LMJ; Klein B; Bouti P; Olsman H; Schornagel K; Kok I; Sunak A; Leeuwenburg K; Timmerman I; Dierselhuis MP; Kholosy WM; Molenaar JJ; van Bruggen R; van den Berg TK; Kuijpers TW; Matlung HL; Tytgat GAM; Franke K
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harnessing T-cell activity against prostate cancer: A therapeutic microparticulate oral cancer vaccine.
    Parenky AC; Akalkotkar A; Mulla NS; D'Souza MJ
    Vaccine; 2019 Sep; 37(41):6085-6092. PubMed ID: 31477437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particulate adjuvants can induce macrophage survival, DNA synthesis, and a synergistic proliferative response to GM-CSF and CSF-1.
    Hamilton JA; Byrne R; Whitty G
    J Leukoc Biol; 2000 Feb; 67(2):226-32. PubMed ID: 10670584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection.
    Sasaki Md; Foccacia R; de Messias-Reason IJ
    Vaccine; 2003 Nov; 21(31):4545-9. PubMed ID: 14575766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.